Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, antibiotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, ant-analgesics, gastro-intestinal, topical, oral, and anti-histamines. It provides NOMA MEGAFFECT for stress relief, eye care, memory and blood lipid concentration enhancement, endurance enhancement, and the supply of vitamins and minerals; and NOMA-F gummy, NOMA CHEWABLE tablet, and NOMA GOLD chewable tablet for growth promotion, enhancement of nutritional deficiency, and supply of vitamins. The company was founded in 1945 and is based in Seoul, South Korea.
Metrics to compare | 009300 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship009300PeersSector | |
---|---|---|---|---|
P/E Ratio | 5.8x | 8.9x | −0.5x | |
PEG Ratio | −0.28 | 0.03 | 0.00 | |
Price/Book | 0.5x | 0.9x | 2.6x | |
Price / LTM Sales | 1.2x | 0.6x | 3.3x | |
Upside (Analyst Target) | - | 49.8% | 42.9% | |
Fair Value Upside | Unlock | 13.7% | 6.2% | Unlock |